BISPECIFIC ANTIBODIES IN FRAIL AND ELDERLY MULTIPLE MYELOMA PATIENTS WITH ECOG >1: REAL-WORLD IMPACT OF PERFORMANCE STATUS AND DOSE MODIFICATIONS ON OUTCOMES

2026-04-01

0

PRE

AI

S

Stoumbos, D.

A

Antoniou, A.

L

Lampropoulos, K.

C

Chrysoglou, S.

P

Prifti, C.

P

Panagiotouni, M.

D

Dadakaridou, M.

G

Giourgouli, S.

S

Stefanidis, K.

K

Kotsopoulou, M.

DOI：

Original request for help

Save

Abstract

En